comparemela.com
Home
Live Updates
USPTO Updates Guidance On Enablement : comparemela.com
USPTO Updates Guidance On Enablement
In 2023, the U.S. Supreme Court affirmed invalidity of two Amgen patents based on a lack of enablement for broad genus claims that would potentially encompass millions of antibodies. The Court1...
Related Keywords
Justice Gorsuch
,
Proprotein Convertase Subtilisin Kexin
,
Baxalta Incorporated
,
Supreme Court
,
Us Supreme Court
,
Medytox Inc
,
Amgen Inc
,
Amgen
,
Genetech Inc
,
Trademark Office
,
Patent Statute
,
Federal Circuit
,
Wands Factors
,
Markets
,
comparemela.com © 2020. All Rights Reserved.